Resultados de la búsqueda 1851-1860 of 18150 for physical exercise
... of advance care planning April 11, 2025, 12:46 p.m. CDT. 2024. Dispose of unused medications safely this Take Back Day Oct. 22, 2024, 04:00 p.m. CDT · Mayo ...
Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability, and preliminary antitumor activity of REGN5458 in ...
The purpose of this study is to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with Cemiplimab. The study ...
The purpose of part two of this study is to evaluate safety and tolerability and evidence of anticancer activity of Q901 as monotherapy and in combination with ...
The purpose of this study is to learn if the study drug, [225Ac]Ac-PSMA-R2, is safe and tolerable, and has anti-tumor activity in treated patients. A Study of ...
The purpose of this study is to evaluate the impact of the location of SQ ... activity of REGN5458 in combination with other cancer treatments for ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?